威高介入集团旗下深圳市金瑞凯利生物科技有限公司自主研发的金属药物支架系统,近日成功通过俄罗斯相关监管部门审核,正式获得俄罗斯医疗器械注册证。这一里程碑标志着该产品品质与安全性获国际认可,为威高介入进一步开拓俄罗斯及欧亚市场奠定了坚实基础。威高介入始终坚持以创新驱动发展,严格遵循国际质量标准,此次注册证的取得,不仅体现了公司在体系与合规方面的实力,也展现了其服务全球医疗需求的决心。未来,威高介入将...
Source Link威高介入集团旗下深圳市金瑞凯利生物科技有限公司自主研发的金属药物支架系统,近日成功通过俄罗斯相关监管部门审核,正式获得俄罗斯医疗器械注册证。这一里程碑标志着该产品品质与安全性获国际认可,为威高介入进一步开拓俄罗斯及欧亚市场奠定了坚实基础。威高介入始终坚持以创新驱动发展,严格遵循国际质量标准,此次注册证的取得,不仅体现了公司在体系与合规方面的实力,也展现了其服务全球医疗需求的决心。未来,威高介入将...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.